Sort
1,049,261 grants matching “t cell”
Mechanisms of Atherogenesis in Insulin Resistance
$1,985,122Ira A Tabas · Columbia University Health Sciences · P01 · FY2018 · HL
NK Cells, Their Receptors and Unrelated Donor Transplant
$1,985,078Jeffrey S Miller · University Of Minnesota · P01 · FY2006 · CA
AAV Gene Therapy for Lipid Disorders
$1,985,074James M Wilson · University Of Pennsylvania · P01 · FY2016 · HL
The impact of changes in chromatin architecture on cancer phenotypes and tumor progression
$1,984,949Jane Amanda Skok · New York University School Of Medicine · P01 · FY2022 · CA
The impact of changes in chromatin architecture on cancer phenotypes and tumor progression
$1,984,949Jane Amanda Skok · New York University School Of Medicine · P01 · FY2023 · CA
Augmented Injury due to Autologous Inflammatory Attack
$1,984,881Francis D Moore · Brigham And Women'S Hospital · P50 · FY2009 · GM
Characterization of in vivo neuronal and inter-neuronal responses to transcranial focused ultrasound
$1,984,876Bin He · Carnegie-Mellon University · R01 · FY2021 · NS
Mapping the vulnerable locus coeruleus pathways in aging and AD
$1,984,794Kwanghun Chung · Massachusetts Institute Of Technology · U01 · FY2022 · AG
Studies of Joint Aging and Osteoarthritis
$1,984,784Martin K. Lotz · Scripps Research Institute, The · P01 · FY2016 · AG
TAS::89 0211::TAS RECOVERY ACT: PHASE III XLERATOR PROGRAM- ELECTRODEPOSITED MN-CO ALLOY COATING FOR SOLID OXIDE FUEL CELL INTERCONNECTS
$1,984,784Faraday Technology, Inc. · · FY2010 · Department of Energy
Transgenic resources for neuroscience research
$1,984,775James Pickel · National Institute Of Mental Health · ZIC · FY2014 · MH
High Performance Computing for Biomedical Research
$1,984,664Joel R. Stiles · Carnegie-Mellon University · P41 · FY2006 · RR
First-in-Human (Phase 1) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of IBC-Ab002 in Persons with Early Alzheimer's Disease (AD)
$1,984,624Eti Yoles · Immunobrain Checkpoint Inc. · R01 · FY2021 · AG
Cytopathology Core
$1,984,623Armando Filie · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
IGF::OT::IGF R&D- NANOEMULSION FORMULATION AND IND-ENABLING STUDIES OF A NOVEL CENTER STEM CELL CYTOTOXIC AGENT
$1,984,617James Egan · Targagenix, Inc. · N44 · FY2016 · CA
Host-tumor cell interaction in myeloma: therapeutic applications
$1,984,614Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Duke SPORE in Brain Cancer
$1,984,462John H Sampson · Duke University · P50 · FY2020 · CA
Liquid biopsy and radiomics for liver cancer surveillance
$1,984,454Bachir Taouli · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA
EFRI-HyBi: Lignin Deconstruction for the Production of Liquid Fuels
$1,984,322Rodney J Andrews · University Of Kentucky Research Foundation · · FY2009 · ENG
Longitudinal validation of retinal biomarkers against cerebral imaging in preclinical Alzheimer's disease
$1,984,309Jessica Alber · University Of Rhode Island · R01 · FY2025 · AG
Genes and signals controlling mammalian hematopoiesis.
$1,984,290Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$1,984,196Ofer Levy · Boston Children'S Hospital · U19 · FY2019 · AI
Genomic Resource for the Yeast Saccharomyces
$1,984,127Joe Michael Cherry · Stanford University · U41 · FY2020 · HG
The Arterial Wall and Atherogenesis in Mice and Humans
$1,984,094Columbia University Health Sciences · P50 · FY2005 · HL
ADULT AIDS CLINICAL TRIALS UNIT
$1,984,093Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2001 · AI